Target Price | $33.66 |
Price | $23.90 |
Potential |
40.84%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Assembly Biosciences, Inc. 2026 .
The average Assembly Biosciences, Inc. target price is $33.66.
This is
40.84%
register free of charge
$52.50
119.67%
register free of charge
$29.29
22.55%
register free of charge
|
|
A rating was issued by 9 analysts: 7 Analysts recommend Assembly Biosciences, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Assembly Biosciences, Inc. stock has an average upside potential 2026 of
40.84%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 28.52 | 32.07 |
298.32% | 12.44% | |
EBITDA Margin | -158.80% | -145.36% |
82.29% | 8.46% | |
Net Margin | -140.88% | -118.97% |
83.53% | 15.55% |
6 Analysts have issued a sales forecast Assembly Biosciences, Inc. 2025 . The average Assembly Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Assembly Biosciences, Inc. EBITDA forecast 2025. The average Assembly Biosciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Assembly Biosciences, Inc. Analysts have issued a net profit forecast 2025. The average Assembly Biosciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -6.69 | -4.97 |
50.00% | 25.71% | |
P/E | negative | |
EV/Sales | 7.64 |
6 Analysts have issued a Assembly Biosciences, Inc. forecast for earnings per share. The average Assembly Biosciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Assembly Biosciences, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Guggenheim |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 27 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 24 2024 |
Jefferies |
Locked
➜
Locked
|
Locked | Sep 20 2024 |
Analyst Rating | Date |
---|---|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 25 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 24 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 27 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 24 2024 |
Locked
Jefferies:
Locked
➜
Locked
|
Sep 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.